1. Home
  2. KDLY vs AIMD Comparison

KDLY vs AIMD Comparison

Compare KDLY & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • AIMD
  • Stock Information
  • Founded
  • KDLY 2019
  • AIMD 1984
  • Country
  • KDLY United States
  • AIMD United States
  • Employees
  • KDLY N/A
  • AIMD N/A
  • Industry
  • KDLY
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • KDLY
  • AIMD Health Care
  • Exchange
  • KDLY NYSE
  • AIMD Nasdaq
  • Market Cap
  • KDLY 9.5M
  • AIMD 9.9M
  • IPO Year
  • KDLY 2024
  • AIMD N/A
  • Fundamental
  • Price
  • KDLY $1.71
  • AIMD $0.55
  • Analyst Decision
  • KDLY
  • AIMD
  • Analyst Count
  • KDLY 0
  • AIMD 0
  • Target Price
  • KDLY N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • KDLY 104.7K
  • AIMD 198.1K
  • Earning Date
  • KDLY 05-03-2025
  • AIMD 05-12-2025
  • Dividend Yield
  • KDLY N/A
  • AIMD N/A
  • EPS Growth
  • KDLY N/A
  • AIMD N/A
  • EPS
  • KDLY N/A
  • AIMD N/A
  • Revenue
  • KDLY $2,719,840.00
  • AIMD $20,729.00
  • Revenue This Year
  • KDLY N/A
  • AIMD N/A
  • Revenue Next Year
  • KDLY N/A
  • AIMD N/A
  • P/E Ratio
  • KDLY N/A
  • AIMD N/A
  • Revenue Growth
  • KDLY N/A
  • AIMD N/A
  • 52 Week Low
  • KDLY $0.65
  • AIMD $0.40
  • 52 Week High
  • KDLY $5.25
  • AIMD $1.46
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • AIMD 52.13
  • Support Level
  • KDLY N/A
  • AIMD $0.52
  • Resistance Level
  • KDLY N/A
  • AIMD $0.59
  • Average True Range (ATR)
  • KDLY 0.00
  • AIMD 0.05
  • MACD
  • KDLY 0.00
  • AIMD 0.00
  • Stochastic Oscillator
  • KDLY 0.00
  • AIMD 50.00

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: